Pulmatrix, Inc.
PULMBiotechnology
$1.42−5.67%As of Oct 29vs prior close
- Market cap
- $5.2M
- P/E (TTM)
- –
- From 52W high
- −71.36%
- EPS (LTM)
- -$1.10
- Revenue (YE24)
- $7.8M
- Dividend yield
- 0.00%
Nomior Score
25
Steady ProfileSpeculativeBottom 10% of the scored universe
Growth—
Quality31
Value—
Momentum12
Resilience37
Growth
+32.23%revenue a year over 8 fiscal years
YE16 $835KYE24 $7.8M
Connections
Revenue to profitQ4 YE24
The operating loss was 65067% of revenue, wider by 64966 pts on a year.